SFM
FSTX

Sphera Funds Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Sphera Funds Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,754
Closed -$535K – 117
2019
Q1 		$535K Hold
12,754
– – 0.05% 98
2018
Q4 		$530K Buy
+12,754
New +$574K 0.06% 93
2018
Q1 		– Sell
-18,577
Closed -$999K – 153
2017
Q4 		$999K Sell
18,577
-21,277
-53% -$1.27M 0.12% 113
2017
Q3 		$2.69M Sell
39,854
-3,896
-9% -$223K 0.38% 67
2017
Q2 		$2.37M Buy
+43,750
New +$2.03M 0.4% 75

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sphera Funds Management's FSTX Position: Q2 2019 in Review

Sphera Funds Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 12,754 shares — an estimated $535K sold.

Sphera Funds Management first reported a position in FSTX in Q2 2017 and held it in 5 quarters. The position peaked at $2.69M in Q3 2017. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • Sphera Funds Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Sphera Funds Management sold 12,754 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $535K.
  • Sphera Funds Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 5 quarters.
  • Sphera Funds Management's F-star Therapeutics, Inc. Common Stock position peaked at $2.69M in Q3 2017.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.